Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2019-05-02 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report Q1 2019' and contains comprehensive financial statements, including income statements, balance sheet data, and detailed management analysis of financial performance for the first quarter of 2019. It is not an announcement of a report, but the report itself, containing substantive financial data and operational commentary. Q1 2019
2019-05-02 English
Annual Report 2018
Annual Report Classification · 1% confidence The document is titled 'Årsredovisning 2018' (Annual Report 2018) for the company Orexo. It contains a comprehensive overview of the company's activities, financial statements, notes, board of directors' report, and auditor's report for the full fiscal year 2018. It is clearly a full annual report rather than an announcement or a summary. FY 2018
2019-03-21 Swedish
Annual Report 2018
Annual Report Classification · 1% confidence The document is explicitly titled 'Annual Report 2018' and contains comprehensive sections including a CEO interview, business objectives, sustainability report, board of directors report, full financial statements, notes, and auditor's report. It covers the company's performance for the full fiscal year 2018, fitting the definition of a 10-K (Annual Report). FY 2018
2019-03-21 English
Kallelse till årsstämma i Orexo
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Orexo" (Notice of Annual General Meeting in Orexo) and details the date, time, location, registration procedures, and a full agenda for the meeting. The agenda items cover standard AGM topics such as election of the chairman, approval of the agenda, election of the board and auditors, approval of remuneration guidelines, and proposals regarding share issuance and incentive programs. This content is characteristic of the official notice calling shareholders to the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2019-03-05 Swedish
Notice of Annual General Meeting of Orexo
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Orexo" and details the date, location, procedures for shareholder participation, and the proposed agenda for the meeting. The agenda items cover standard AGM topics like electing the chairman, approving the annual report, approving remuneration guidelines, and authorizing share issuances/repurchases. This content perfectly matches the definition of AGM Information, which corresponds to the code AGM-R.
2019-03-05 English
Antal aktier och röster i Orexo
Share Issue/Capital Change Classification · 1% confidence The document is a short press release (1691 characters) titled "Antal aktier och röster i Orexo" (Number of shares and votes in Orexo). It explicitly states that the number of shares and votes has changed due to the exercise of warrants within an incentive program, providing the new total count of shares and votes as of the last trading day of the month. This type of announcement, detailing changes in the total number of outstanding shares or voting rights, most closely aligns with announcements related to capital structure changes or significant shareholding notifications. Since it is a direct announcement of a change in the total share count, it fits best under 'Share Issue/Capital Change' (SHA) or potentially 'Major Shareholding Notification' (MRQ) if the change crossed a threshold, but the focus here is the total count resulting from an option exercise. Given the options, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for reporting the resulting total share count after an issuance event (warrant exercise). It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It is a specific regulatory disclosure about the share base.
2019-02-28 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.